An Updated Review of Randomized Clinical Trials Testing the Improvement of Cognitive Function of Ginkgo biloba Extract in Healthy People and Alzheimer's Patients

Frontiers in Pharmacology
Haolong LiuHongzhu Guo

Abstract

Alzheimer's disease (AD) is a common neurodegenerative disease, mainly manifested by cognitive dysfunction. It seriously reduces the quality of life, and there is no ideal treatment strategy in clinical practice. Clinical studies on the treatment of AD with Ginkgo biloba L. leaf extract (EGb) have been reported since 1980s, and many clinical studies have been carried out during the following 30 years. However, the benefits of EGb on the treatment of AD are still controversial. In this review, we collected the clinical trial reports of EGb on cognitive function from Pubmed, Elsevier, Europe PMC, and other database since the 1980s. Through analysis and comparison, we consider that EGb may be able to improve the cognitive function in patients who suffered from mild dementia during long-term administration (more than 24 weeks) and appropriate dosage (240 mg per day). The main evidences and existing problems of the negative and positive experimental results were summarized.

References

Oct 29, 1997·JAMA : the Journal of the American Medical Association·P L Le BarsA F Schatzberg
Feb 3, 1998·Journal of Psychiatric Research·K MaurerL Frölich
Jun 27, 2000·Dementia and Geriatric Cognitive Disorders·P L Le BarsK Z Itil
Jul 24, 2001·The International Journal of Neuropsychopharmacology·C StoughP J Nathan
May 28, 2003·Journal of Clinical Epidemiology·Martien van DongenPaul Knipschild
Mar 3, 2004·Human Psychopharmacology·Richard D Mattes, M Kate Pawlik
Dec 6, 2005·Human Psychopharmacology·Nicholas R BurnsTed Nettelbeck
Aug 26, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M MazzaS Mazza
Mar 17, 2009·Journal of the Neurological Sciences·Oleksandr NapryeyenkoIgor Tartakovsky
Nov 15, 2013·Oxidative Medicine and Cellular Longevity·Le LiShi-yuan Xu
Feb 1, 2013·Shanghai Archives of Psychiatry·Lijuan JiangChunbo Li
Dec 3, 2015·Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Société Canadienne Des Sciences Pharmaceutiques·Christoph SteinJochen Klein
Jan 29, 2016·Journal of Pharmaceutical Health Care and Sciences·Masayuki HashiguchiMayumi Mochizuki
Nov 20, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Xiaomei ZhouTing Chen
Apr 19, 2017·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·R M Chávez-MoralesJ A Garfias-López
Jan 11, 2018·International Journal of Clinical Pharmacology and Therapeutics·Michael RappJens Bohlken
Jan 20, 2018·Clinical and Experimental Hypertension : CHE·Ahmed O Abdel-ZaherAhmed M Abd-Eldayem
Sep 14, 2019·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Jinzhou TianUNKNOWN CHARM study group
Nov 30, 2019·Neurología : publicación oficial de la Sociedad Española de Neurología·P C Bello-MedinaS Díaz-Cintra
Dec 1, 2019·Nature Reviews. Neurology·Robert Howard, Kathy Y Liu

❮ Previous
Next ❯

Citations

Oct 4, 2020·Nutrients·Daljeet Singh DhanjalKamil Kuca
Dec 12, 2020·Drug Discovery Today·Shvetank BhattChandragauda R Patil
May 1, 2021·Pharmaceuticals·Carlo TominoPaolo Maria Rossini
May 1, 2021·Biomolecules·Julie GregoryRammohan V Rao
Jul 17, 2021·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Valentina MalafogliaAntonello Bonci
Aug 24, 2021·Frontiers in Nutrition·Maja MiloševićVesna Vučić
Oct 13, 2021·Alzheimer's Research & Therapy·Andrea Brioschi GuevaraGael Chételat

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.